Skip to main content
. 2023 Jan 27;13(2):229. doi: 10.3390/jpm13020229

Table 3.

Treatment outcomes.

Outcome Total (%) (IQR)
Follow-up
Median (range) 18 (10.5–31)
Median survival 22 (12.5–34.5)
Radiological response
CR 18 (62%)
PR 8 (28%)
SD 1 (3%)
PD 2 (7%)
Acute toxicities
G1-G2 4 (18%)
No 18 (82%)

CR: complete response; G: grade; PD: progression disease; PR: partial response; SBRT: stereotactic body radiotherapy; SD: stable disease.